332 related articles for article (PubMed ID: 20206649)
1. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.
Dumas de la Roque E; Savineau JP; Bonnet S
Pharmacol Ther; 2010 May; 126(2):186-99. PubMed ID: 20206649
[TBL] [Abstract][Full Text] [Related]
2. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular pathobiology of pulmonary arterial hypertension.
Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
6. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
Bonnet S; Rochefort G; Sutendra G; Archer SL; Haromy A; Webster L; Hashimoto K; Bonnet SN; Michelakis ED
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11418-23. PubMed ID: 17596340
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary arterial hypertension: new insights and new hope.
Martin KB; Klinger JR; Rounds SI
Respirology; 2006 Jan; 11(1):6-17. PubMed ID: 16423196
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
[TBL] [Abstract][Full Text] [Related]
9. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
Kayikçioğlu M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
[TBL] [Abstract][Full Text] [Related]
10. DHEA treatment of pulmonary hypertension: new insights into a complex mechanism.
Dubuis E
Cardiovasc Res; 2007 Jun; 74(3):337-8. PubMed ID: 17466961
[No Abstract] [Full Text] [Related]
11. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary hypertension: the role of nitric oxide in adults].
Neidecker J
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):457-9. PubMed ID: 11792299
[TBL] [Abstract][Full Text] [Related]
13. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
[TBL] [Abstract][Full Text] [Related]
14. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
Moudgil R; Michelakis ED; Archer SL
Microcirculation; 2006 Dec; 13(8):615-32. PubMed ID: 17085423
[TBL] [Abstract][Full Text] [Related]
15. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cells through 5-HT2A receptors involved in the pulmonary artery remodeling of pulmonary artery hypertension.
Liu Y; Tian H; Yan X; Fan F; Wang W; Han J
Exp Lung Res; 2013 Mar; 39(2):70-9. PubMed ID: 23301505
[TBL] [Abstract][Full Text] [Related]
16. Current therapeutics and practical management strategies for pulmonary arterial hypertension.
Agarwal R; Gomberg-Maitland M
Am Heart J; 2011 Aug; 162(2):201-13. PubMed ID: 21835279
[TBL] [Abstract][Full Text] [Related]
17. Current insights on the pathogenesis of pulmonary arterial hypertension.
Perros F; Dorfmüller P; Humbert M
Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
[TBL] [Abstract][Full Text] [Related]
18. [Effect of dehydroepiandrosterone on Ca(2+)-activated K+ channel of pulmonary arterial smooth muscle cells in pulmonary hypertensive rats].
Xiao XR; Chen WB; Cheng DY; Chen Z
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):41-5. PubMed ID: 14989825
[TBL] [Abstract][Full Text] [Related]
19. Emerging therapies for the treatment of pulmonary hypertension.
Stenmark KR; Rabinovitch M
Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S85-90. PubMed ID: 20216170
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
Humbert M; Montani D; Perros F; Dorfmüller P; Adnot S; Eddahibi S
Vascul Pharmacol; 2008; 49(4-6):113-8. PubMed ID: 18606248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]